Related Experiment Video
Updated: Jul 15, 2026
04:52
Dynamic Continuous Blood Extraction from Rat Heart via Noninvasive Microdialysis Technique
Published on: September 13, 2022
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives
Chandra S Chaurasia1, Markus Müller, Edward D Bashaw
1Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration, Rockville, MD, USA. chandra.chaurasia@fda.hhs.gov
Pharmaceutical Research
|April 27, 2007
Summary
Tissue drug concentration, not blood levels, is key for understanding drug effects. Microdialysis (microD) measures drug concentrations in tissue extracellular fluid, offering more relevant data for drug development and clinical practice.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Development
Background:
- Clinical decisions often rely on blood molecule concentrations, but drug effects occur in tissues.
- Most drugs act within target tissues, necessitating tissue-level analysis for meaningful data.
- The extracellular tissue space is critical as it represents the drug's biophase.
Framework:
- Microdialysis (microD) is the sole technique providing direct measurements of the extracellular tissue space.
- This method offers a more rational approach to assessing drug disposition and effect compared to blood sampling.
Implementation:
- An AAPS-FDA workshop in November 2005 addressed microdialysis in drug research.
- The workshop aimed to clarify methodological and regulatory uncertainties surrounding microdialysis use.
- Experts from academia, industry, and regulatory bodies shared insights on microdialysis applications.
Implications:
- Addressing uncertainties can enhance the adoption of microdialysis in drug research and development.
- Improved understanding of tissue drug concentrations can lead to more effective drug therapies.
- Microdialysis data provides clinically relevant insights for drug efficacy and safety assessments.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:15Dialysis
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...